Cargando…
The Effect of Heat Shock Protein 90 Inhibitor on Pain in Cancer Patients: A Systematic Review and Meta-Analysis
Background and objectives: Heat shock protein 90 (Hsp90) is a molecular chaperone that plays an essential role in tumor growth. Numerous Hsp90 inhibitors have been discovered and tested in preclinical and clinical trials. Recently, several preclinical studies have demonstrated that Hsp90 inhibitors...
Autores principales: | Miles, Victoria N., Patel, Roma K., Smith, Amanda G., McCall, Ryan P., Wu, Jun, Lei, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822414/ https://www.ncbi.nlm.nih.gov/pubmed/33374669 http://dx.doi.org/10.3390/medicina57010005 |
Ejemplares similares
-
Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma
por: Wu, Xinqi, et al.
Publicado: (2013) -
Heat shock protein 90 inhibitors repurposed against Entamoeba histolytica
por: Shahinas, Dea, et al.
Publicado: (2015) -
Molecular docking and pharmacophore studies of heterocyclic compounds
as Heat shock protein 90 (Hsp90) Inhibitors
por: Baby, Suby T, et al.
Publicado: (2016) -
Heat shock protein 90 (HSP90) inhibitors in gastrointestinal cancer: where do we currently stand?—A systematic review
por: Magyar, Christian Tibor Josef, et al.
Publicado: (2023) -
Synergism of Heat Shock Protein 90 and Histone Deacetylase Inhibitors in Synovial Sarcoma
por: Nguyen, Anne, et al.
Publicado: (2009)